Xingbo Xu

1.9k total citations
46 papers, 1.4k citations indexed

About

Xingbo Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xingbo Xu has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xingbo Xu's work include Renal and related cancers (7 papers), CRISPR and Genetic Engineering (6 papers) and Pluripotent Stem Cells Research (6 papers). Xingbo Xu is often cited by papers focused on Renal and related cancers (7 papers), CRISPR and Genetic Engineering (6 papers) and Pluripotent Stem Cells Research (6 papers). Xingbo Xu collaborates with scholars based in Germany, China and United States. Xingbo Xu's co-authors include Elisabeth M. Zeisberg, Michael Zeisberg, Xiao-Ying Tan, Björn Tampe, Raghu Kalluri, Melanie S. Hulshoff, Elisa Sánchez, D. V. Krishna Pantakani, Wolfgang Engel and Guido Krenning and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xingbo Xu

43 papers receiving 1.4k citations

Peers

Xingbo Xu
Takayoshi Matsumura Japan
Hai Tao Yuan United Kingdom
Alka Jain United States
Zouhair Aherrahrou Germany
Kenichi Aizawa Japan
Michèle Souyri France
Ljubica Perisic Sweden
Rajeev Mahimkar United States
László Hegyi United Kingdom
Mark de Caestecker United States
Takayoshi Matsumura Japan
Xingbo Xu
Citations per year, relative to Xingbo Xu Xingbo Xu (= 1×) peers Takayoshi Matsumura

Countries citing papers authored by Xingbo Xu

Since Specialization
Citations

This map shows the geographic impact of Xingbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Xu more than expected).

Fields of papers citing papers by Xingbo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Xu. The network helps show where Xingbo Xu may publish in the future.

Co-authorship network of co-authors of Xingbo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingbo Xu. A scholar is included among the top collaborators of Xingbo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingbo Xu. Xingbo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Xiao-Ying, et al.. (2025). CRISPR/Cas13-Based Anti-RNA Viral Approaches. Genes. 16(8). 875–875. 1 indexed citations
2.
Wang, Jianzhang, Yajuan Song, Xiao-Ying Tan, et al.. (2025). CILP1 interacting with YBX1 promotes hypertrophic scar formation by suppressing PPARs transcription. Cell Death and Disease. 16(1). 371–371.
3.
Xu, Xingbo, Xiao-Ying Tan, Moritz Schnelle, et al.. (2023). DNA Methylation Analysis Identifies Novel Epigenetic Loci in Dilated Murine Heart upon Exposure to Volume Overload. International Journal of Molecular Sciences. 24(6). 5885–5885.
4.
Hulshoff, Melanie S., Isabel N. Schellinger, Xingbo Xu, et al.. (2023). miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 15(1). 11–11. 12 indexed citations
5.
Xu, Xingbo, Elisabeth M. Zeisberg, Hanibal Bohnenberger, et al.. (2023). Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Molecular Cancer. 22(1). 17–17. 28 indexed citations
6.
Klein, Lukas, Florian Wegwitz, Elisa Espinet, et al.. (2022). Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. JCI Insight. 7(16). 5 indexed citations
7.
An, Qing, Shuwen Su, Yan Tu, et al.. (2021). Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease. 12. 364105306–364105306. 3 indexed citations
8.
Xu, Xingbo, et al.. (2021). Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?. Frontiers in Cardiovascular Medicine. 8. 678121–678121. 13 indexed citations
9.
Zeng, Qingchun, et al.. (2020). Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation. Therapeutic Advances in Chronic Disease. 11. 1754240844–1754240844. 2 indexed citations
10.
Xu, Xingbo, Xiao-Ying Tan, Björn Tampe, et al.. (2018). High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis. Nature Communications. 9(1). 3509–3509. 107 indexed citations
11.
Hulshoff, Melanie S., Sandip Kumar Rath, Xingbo Xu, Michael Zeisberg, & Elisabeth M. Zeisberg. (2018). Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis. Seminars in Nephrology. 38(6). 629–636. 13 indexed citations
12.
Tan, Xiao-Ying, Xingbo Xu, Michael Zeisberg, & Elisabeth M. Zeisberg. (2016). DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition. PLoS ONE. 11(1). e0147816–e0147816. 26 indexed citations
13.
Liu, Xiaopeng, Jing Qi, Xingbo Xu, et al.. (2016). Differentiation of functional endothelial cells from human induced pluripotent stem cells: A novel, highly efficient and cost effective method. Differentiation. 92(4). 225–236. 27 indexed citations
14.
Tan, Xiao-Ying, Xingbo Xu, Elisabeth M. Zeisberg, & Michael Zeisberg. (2016). High inorganic phosphate causes DNMT1 phosphorylation and subsequent fibrotic fibroblast activation. Biochemical and Biophysical Research Communications. 472(3). 459–464. 18 indexed citations
15.
Xu, Xingbo, Xiao-Ying Tan, Björn Tampe, et al.. (2015). Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells. Journal of Biological Chemistry. 290(27). 16653–16664. 141 indexed citations
16.
Xu, Xingbo, et al.. (2014). Pelota regulates the development of extraembryonic endoderm through activation of bone morphogenetic protein (BMP) signaling. Stem Cell Research. 13(1). 61–74. 11 indexed citations
17.
Charytan, David M., Robert F. Padera, Michael Zeisberg, et al.. (2014). Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. International Journal of Cardiology. 176(1). 99–109. 84 indexed citations
18.
Tampe, Björn, Désirée Tampe, Claudia Müller, et al.. (2014). Tet3-Mediated Hydroxymethylation of Epigenetically Silenced Genes Contributes to Bone Morphogenic Protein 7-Induced Reversal of Kidney Fibrosis. Journal of the American Society of Nephrology. 25(5). 905–912. 112 indexed citations
19.
Tan, Xiao-Ying, Xingbo Xu, Lukasz Smorag, et al.. (2013). Zfp819, a novel KRAB-zinc finger protein, interacts with KAP1 and functions in genomic integrity maintenance of mouse embryonic stem cells. Stem Cell Research. 11(3). 1045–1059. 39 indexed citations
20.
Wiggs, Janey L., Basil S. Pawlyk, E. Connolly, et al.. (2009). Phenotypic Characterization of the LOXL1 Null Mouse. Investigative Ophthalmology & Visual Science. 50(13). 882–882. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayoshi Matsumura Breakdown of academic impact, for papers by Hai Tao Yuan Breakdown of academic impact, for papers by Alka Jain Breakdown of academic impact, for papers by Zouhair Aherrahrou Breakdown of academic impact, for papers by Kenichi Aizawa Breakdown of academic impact, for papers by Michèle Souyri Breakdown of academic impact, for papers by Ljubica Perisic Breakdown of academic impact, for papers by Rajeev Mahimkar Breakdown of academic impact, for papers by László Hegyi Breakdown of academic impact, for papers by Mark de Caestecker
Rankless by CCL
2026